enVVeno Medical Corporation
NVNO
$4.87
$0.265.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.76% | -3.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.05% | 8.57% | |||
| Operating Income | 26.05% | -8.57% | |||
| Income Before Tax | 27.71% | -10.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.71% | -10.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.71% | -10.40% | |||
| EBIT | 26.05% | -8.57% | |||
| EBITDA | 26.21% | -8.68% | |||
| EPS Basic | 27.61% | 12.96% | |||
| Normalized Basic EPS | 27.48% | 15.19% | |||
| EPS Diluted | 27.61% | 12.96% | |||
| Normalized Diluted EPS | 27.48% | 15.19% | |||
| Average Basic Shares Outstanding | -0.13% | 26.84% | |||
| Average Diluted Shares Outstanding | -0.13% | 26.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||